Business
Ligand to Ring the Nasdaq Opening Bell on May 19, 2025
JUPITER, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that the company will ring The Nasdaq Stock Market Opening Bell on Monday, May 19, 2025. CEO Todd Davis will be joined by members of Ligand’s senior management team and board of directors to commemorate several recent company milestones, including two value-creating transactions. “Ringing the Nasdaq Opening Bell marks an exciting milestone in our company’s history. Over the past few
About this update from Ligand Pharmaceuticals Incorporated
[{"type":"image","alt":"Ligand Pharmaceuticals","displaySize":"","headline":null,"caption":"Ligand Pharmaceuticals","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":105,"url":"https://media.zenfs.com/en/globenewswire.com/e824ed3c4822e04f01467c6db4017595"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Yrpe7ervqRZN98EXhfJlGA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0NztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/e824ed3c4822e04f01467c6db4017595","width":300,"height":105}},"lazy":false},{"type":"text","content":"JUPITER, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that the company will ring The Nasdaq Stock Market Opening Bell on Monday, May 19, 2025. CEO Todd Davis will be joined by members of Ligand’s senior management team and board of directors to commemorate several recent company milestones, including two value-creating transactions.","length":395,"tagName":"p"},{"type":"text","content":"“Ringing the Nasdaq Opening Bell marks an exciting milestone in our company’s history. Over the past few years, we have made significant progress in transforming Ligand into a profitable and infrastructure-light organization focused on acquiring and generating royalties from a diverse portfolio of biopharmaceutical products,” said Todd Davis, CEO of Ligand. “Looking ahead, we remain committed to building on the momentum we’ve achieved over the past two years, supporting our partners in developing breakthrough medicines for patients, and creating long-term value for our shareholders.”","length":590,"tagName":"p"},{"type":"text","content":"The live broadcast of the Nasdaq Opening Bell ceremony will begin at 9:15 a.m. Eastern Time and will be available at https://www.nasdaq.com/marketsite/bell-ringing-ceremony.","length":183,"tagName":"p"},{"type":"text","content":"About Ligand PharmaceuticalsLigand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing financing, licensing our technologies or both. Our business model seeks to generate value for stockholders by creating a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an o...